{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:23:27Z","timestamp":1791181407092,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.vaccine.2015.06.112","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T03:28:18Z","timestamp":1437449298000},"page":"4221-4227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone"],"prefix":"10.1016","volume":"33","author":[{"given":"Julie","family":"Medina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Boukhebza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"De Saint Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Sodoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Legastelois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Moste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.06.112_bib0095","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.vaccine.2010.12.044","article-title":"The development of vaccine viruses against pandemic A(H1N1) influenza","volume":"29","author":"Robertson","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0100","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1016\/j.vaccine.2012.04.073","article-title":"Increased hemagglutinin content in a reassortant 2009 pandemic H1N1 influenza virus with chimeric neuraminidase containing donor A\/Puerto Rico\/8\/34 virus transmembrane and stalk domains","volume":"30","author":"Jing","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0105","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1128\/JVI.00096-11","article-title":"Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric hemagglutinin molecules","volume":"85","author":"Harvey","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0110","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.1016\/j.vaccine.2010.09.006","article-title":"Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules","volume":"28","author":"Harvey","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0115","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1128\/JVI.02391-08","article-title":"Optimizing viral protein yield of influenza virus strain A\/Vietnam\/1203\/2004 by modification of the neuraminidase gene","volume":"83","author":"Adamo","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0120","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/nar\/gkr985","article-title":"A supramolecular assembly formed by influenza A virus genomic RNA segments","volume":"40","author":"Fournier","year":"2012","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jviromet.2013.09.007","article-title":"Vero\/CHOK1, a novel mixture of cell lines that is optimal for the rescue of influenza A vaccine seeds","volume":"196","author":"Medina","year":"2014","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jviromet.2011.08.027","article-title":"Avian glycan-specific IgM monoclonal antibodies for the detection and quantitation of type A and B haemagglutinins in egg-derived influenza vaccines","volume":"178","author":"Legastelois","year":"2011","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1750-2659.2007.00015.x","article-title":"Preparation of genetically engineered A\/H5N1 and A\/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells","volume":"1","author":"Legastelois","year":"2007","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4149\/av_2011_03_195","article-title":"Analysis of antigen epitopes and molecular pathogenic characteristics of the 2009 H1N1 pandemic influenza A virus in China","volume":"55","author":"Zhou","year":"2011","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0145","series-title":"Meeting Report \u2013 Joint EMA\/EDQM workshop on improved potency assays for inactivated influenza vaccines, 12 December 2011","author":"European Medicines Agency L, UK","year":"2011"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0147-9571(80)90059-4","article-title":"Contribution to the control of inactivated human influenza vaccines with the single radial diffusion method (SRD): routine check, industrial supervision and vaccine standardisation","volume":"3","author":"Larbaigt","year":"1980","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0155","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.virusres.2009.10.010","article-title":"Enhancement of reverse genetics-derived swine-origin H1N1 influenza virus seed vaccine growth by inclusion of indigenous polymerase PB1 protein","volume":"147","author":"Wanitchang","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/rmv.352","article-title":"Functional balance between haemagglutinin and neuraminidase in influenza virus infections","volume":"12","author":"Wagner","year":"2002","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nsmb.1574","article-title":"Universal epitopes of influenza virus hemagglutinins?","volume":"16","author":"Wang","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0175","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.06.112_bib0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T19:59:17Z","timestamp":1537473557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15009810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":18,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0264410X15009810"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.112","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}